Position in FATE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,944,240
+$2,070,985 QoQ
Shares Held
4,120,200
+40.5% QoQ
Ownership
3.53%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $703,385,515 across 179 Biotechnology names. FATE ranks #28 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,905,554 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,816,214 | |
| 3 | QNCX |
Quince Therapeutics, Inc.
|
1,750,862 | $35,367,412 | |
| 4 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,629,508 | |
| 5 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,718,828 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,020,159 | |
| 7 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,107,893 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,042,603 |
All Filings in FATE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,944,240 | 4,120,200 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,873,255 | 2,931,893 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $3,414,894 | 2,710,234 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,755,148 | 2,459,954 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,954,116 | 2,473,565 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $2,431,756 | 1,473,792 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $5,607,420 | 1,602,120 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,589,067 | 2,008,862 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $12,581,670 | 1,714,124 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,531,579 | 2,281,171 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,557,145 | 2,149,597 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,345,484 | 912,917 | Shares | Defined | 2023-08-07 | |
| No filing history on record for this holder in this stock. | ||||||